CLP-3094 - CAS# 312749-73-8 enolate mofetil Enhanced receptor binding of SARS-CoV-2

Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions

InChi: InChI=1S/C89H126N24O18S/c1-10-12-30-69-82(125)102-60(29-21-33-95-89(92)93)78(121)108-68(77(120)98-44-73(91)116)47-132-48-75(118)101-64(36-52-23-15-14-16-24-52)85(128)110(7)51(5)76(119)104-66(40-72(90)115)87(130)113-34-22-32-70(113)83(126)103-62(39-55-43-94-49-99-55)80(123)105-63(35-50(3)4)84(127)109(6)45-74(117)100-61(37-53-41-96-58-27-19-17-25-56(53)58)79(122)107-67(46-114)81(124)106-65(38-54-42-97-59-28-20-18-26-57(54)59)86(129)112(9)71(31-13-11-2)88(131)111(69)8/h14-20

When administered systemically to mice

Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide

Laserphyrin

CLP-3094 - CAS# 312749-73-8 enolate mofetil Enhanced receptor binding of SARS-CoV-2CLP 3094 is a potent BF3 (binding function 3) directed inhibitor of the androgen receptor (AR). CLP 3094 inhibits AR transcriptional activity (IC50=4 M). CLP 3094 is a selective, potent GPR142 antagonist. Product information CAS Number: 312749 73 8 Molecular Weight: 304. 79 Formula: C15H13ClN2OS Chemical Name: 2 {[2 (4 chlorophenoxy)ethyl]sulfanyl} 1H 1,3 benzodiazole Smiles: ClC1C=CC(=CC=1)OCCSC1NC2=CC=CC=C2N=1 InChiKey: KZEWVENYWPSSOZ UHFFFAOYSA N